Načítá se...
New horizons in ablation therapy for hepatocellular carcinoma
Historically ablative treatment for hepatocellular cancer (HCC) has been regarded as inferior to transplantation and resection and has therefore been reserved for patients not suitable for surgical intervention in stage 0-A HCC according to the Barcelona Clinic Liver Cancer classification system. In...
Uloženo v:
| Vydáno v: | Hepat Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095152/ https://ncbi.nlm.nih.gov/pubmed/30191017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.15.28 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|